Deccan Cements
- Market cap
- ₹ 684 Cr.
- P/E
- 51.9x
- P/B
- 0.92x
- 52-week range
- 473.5 – 1,063.1
- ROE
- 2%
- ROCE
- 3%
- Dividend yield
- 0.1%
- Debt / equity
- 1
- Sector
- Cement & Cement Products
- Industry
- Cement & Cement Products
- Listed on
- NSE, BSE
About
Deccan Cements Limited is an India-based cement production company. The Company is engaged in the manufacturing and selling of cement and the production and selling of power from hydel and wind sources. Its products include Ordinary Portland Cement (OPC), including three different grades, namely, OPC 33 Grade, OPC 43 Grade and OPC 53 Grade cements; Portland Pozzolana Cement (PPC); Portland Slag Cement (PSC) and Specialty Cements, including 53-S grade OPC, rapid hardening cement, high alumina cement, sulphate resistant cement, and oil well cement. Its Power Division includes thermal, hydel and wind plant projects. The Company has two non-conventional power plants. One is a 2.025-megawatt (MW) capacity wind power project, and the other unit is a 3.75 MW Mini Hydel Project. It has also installed a 7.00 MW waste heat recovery power plant to generate energy from waste heat generated from the cement kiln.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Cement & Cement Products: 42 companies →Deccan Cements against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)51.9 against a typical 32.3: pricier than most peers (1st = cheapest).31st of 40
- Sales growth+45.7% against a typical +9.4% from a year earlier.2nd of 37
- Profit growth−118.5% against a typical −31.3% from a year earlier.24th of 28
- Share price, 3 months−14% against a typical −13.2%.21st of 39
- Size₹ 684.2 Cr. market value against a typical ₹ 686.3 Cr. (1st = largest).17th of 32
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated BBB to BB+ by 2 agencies- Infomerics lowered its rating on 20 Aug 2026.
- Infomerics expects things to get worse (negative outlook).
- The company stopped sharing information with CRISIL.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| Infomerics | IVR BB+ /INC | Negative | 20 Aug 2026 |
| CARE | CARE BBB | Stable | 7 Aug 2026 |
| CRISIL | Crisil BB(Issuer Not Cooperating) | Stable | 6 Jul 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 20 Aug 2026 | ▼ Downgrade1 notch | IVR BBB- /INC → IVR BB+ /INC | — | Infomerics | ₹ 25 Cr. | |
| 7 Aug 2026 | ▼ Downgrade1 notch | CARE BBB+ → CARE BBB | — | CARE | ₹ 300 Cr. | |
| 6 Jul 2026 | Rating action | Crisil BB(Issuer Not Cooperating) | — | CRISIL | ₹ 807.02 Cr. | |
| 9 Jun 2026 | ▼ Downgrade2 notches | IVR BBB+ → IVR BBB- /INC | — | Infomerics | ₹ 25 Cr. | |
| 23 Sep 2025 | New rating | IVR BBB+ | — | Infomerics | ₹ 25 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 12 Aug 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026, fix record date for final dividend 2025-26 and other business matters |
| 29 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters |
| 14 May 2026 | Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| 12 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 11 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 12 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 172 | 120 | 115 | 119 | 151 | 140 | 131 | 214 | 219 |
| Expenses | 161 | 118 | 107 | 106 | 123 | 120 | 119 | 197 | 202 |
| Operating Profit | 11 | 2 | 9 | 13 | 28 | 20 | 11 | 17 | 17 |
| OPM % | 6.6% | 1.8% | 7.6% | 11% | 18.5% | 14.4% | 8.7% | 8.1% | 7.7% |
| Other Income | 3 | 3 | 3 | 7 | 3 | 2 | 2 | 14 | 9 |
| Interest | 3 | 3 | 4 | 3 | 3 | 3 | 6 | 15 | 16 |
| Depreciation | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 14 | 16 |
| Profit before tax | 4 | −5 | 1 | 10 | 20 | 12 | −1 | 2 | −5 |
| Tax % | 34.8% | −25.9% | 45.6% | 23.7% | 25% | 27.2% | −20.3% | −135.3% | −42.6% |
| Net Profit | 3 | −4 | 1 | 8 | 15 | 9 | −1 | 5 | −3 |
| EPS in Rs | 2.01 | −2.89 | 0.58 | 5.68 | 10.96 | 6.48 | −0.4 | 3.37 | −2.03 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 39%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −124%
- 10 Years
- 2%
- 5 Years
- −5%
- 3 Years
- 2%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Deccan Cements | ₹ 473.50 | ₹ 684 Cr. | 51.9x | 0.9x | 2% | — |
| UltraTech Cement | ₹ 11,066.00 | ₹ 3,26,092 Cr. | 41.7x | 4.5x | 11.1% | 9.3% |
| Grasim Industries | ₹ 2,898.00 | ₹ 1,95,975 Cr. | 40.8x | 2x | 4.9% | 5.9% |
| Ambuja Cements | ₹ 358.00 | ₹ 88,956 Cr. | 21.9x | 1.8x | 8.3% | 13.8% |
| Shree Cement | ₹ 22,760.00 | ₹ 82,120 Cr. | 55.2x | 4.1x | 7.8% | 8.4% |
| Dalmia Bharat | ₹ 1,591.65 | ₹ 29,801 Cr. | 29.5x | 1.9x | 6.5% | 7.8% |
Management
- Penmetcha Parvathi
- Executive Chairman of the Board, Managing Director
- D. Raghava Chary
- Chief Financial Officer
- Bikram Keshari Prusty
- Compliance Officer, Company Secretary
- Shonti Venkateswarlu
- Whole Time Director, Director - Works
Prices are delayed and for information only. Nothing on this page is investment advice.